🔎 Trials Near Me

Home › Interdigitating Dendritic Cell Sarcoma

Interdigitating Dendritic Cell Sarcoma clinical trials recruiting in the U.S.

7 studies for Interdigitating Dendritic Cell Sarcoma are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

RecruitingPhase 1
1 Day – 21 Years · All sexes · Updated Aug 26, 2026 · NCT05857969

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07121946

SynKIR-310 for Relapsed/Refractory B-NHL

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT06846463

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06736613

Q702 for the Treatment of Patients With Hematologic Malignancies

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Recruiting
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT05940272

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.